Original Research
Published on 05 Feb 2026
Comparative safety of denosumab and romosozumab in osteoporosis: an analysis based on the FDA adverse event reporting system database
in Rheumatology
- 337 views
Original Research
Published on 05 Feb 2026
in Rheumatology
Editorial
Published on 05 Feb 2026
in Embryonic Development
Editorial
Published on 05 Feb 2026
in Bee Physiology
Mini Review
Published on 05 Feb 2026
in Cancer Immunity and Immunotherapy
Review
Published on 05 Feb 2026
in Integrative and Regenerative Pharmacology
Original Research
Published on 05 Feb 2026
in Stem Cell Research
Original Research
Published on 05 Feb 2026
in Cardiovascular Endocrinology
Original Research
Published on 05 Feb 2026
in Cancer Epidemiology and Prevention
Review
Published on 05 Feb 2026
in Tissue Engineering and Regenerative Medicine
Original Research
Published on 05 Feb 2026
in Ophthalmology
Original Research
Published on 05 Feb 2026
in Nutritional Immunology
Editorial
Published on 05 Feb 2026
in Cell Adhesion and Migration
Review
Published on 05 Feb 2026
in Neuro-Otology
Original Research
Published on 05 Feb 2026
in Motor Neuroscience
Review
Published on 05 Feb 2026
in Ophthalmology
Review
Published on 05 Feb 2026
in Cancer Immunity and Immunotherapy